GPP
MNTA

Great Point Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Great Point Partners’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-979,400
Closed -$26.6M – 46
2020
Q1 		$26.6M Sell
979,400
-1,811,000
-65% -$50.4M 2.78% 13
2019
Q4 		$55.1M Buy
2,790,400
+1,790,400
+179% +$28.6M 4.79% 8
2019
Q3 		$13M Buy
1,000,000
+657,936
+192% +$7.94M 1.19% 25
2019
Q2 		$4.26M Buy
342,064
+32,500
+10% +$432K 0.47% 25
2019
Q1 		$4.5M Buy
+309,564
New +$3.95M 0.45% 33
2014
Q2 		– Sell
-62,000
Closed -$722K – 46
2014
Q1 		$722K Buy
+62,000
New +$1.05M 0.38% 36

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Great Point Partners's MNTA Position: Q2 2020 in Review

Great Point Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2020, closing a stake of 979,400 shares — an estimated $26.6M sold.

Great Point Partners first reported a position in MNTA in Q1 2014 and held it in 6 quarters. The position peaked at $55.1M in Q4 2019. 237 funds tracked by Wall St. Rank hold MNTA as of Q2 2020.

  • Great Point Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Great Point Partners sold 979,400 Momenta Pharmaceuticals, Inc. shares in Q2 2020, an estimated $26.6M.
  • Great Point Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 6 quarters.
  • Great Point Partners's Momenta Pharmaceuticals, Inc. position peaked at $55.1M in Q4 2019.
  • 237 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2020.

Based on Great Point Partners's 13F filing for Q2 2020, filed 14 Aug 2020.